Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

about

Cardio-oncology: cardiovascular complications of cancer therapy.The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters".Prevention of cardiotoxicity among survivors of childhood cancer.Effects of ionizing radiation on the heart.Chemotherapy-induced cardiotoxicity in children.

P2860

Q38665281-ED0E5D22-D86B-4884-855E-BB8728524C0D Q38816130-EF0E3A92-7C8A-448F-8AF8-99378CBC68B6 Q38824644-B84CD0CC-57FB-4C3F-B92F-EB1C641D0298 Q39029699-82C9550D-08D5-45ED-8ED3-13B609B74A5C Q39415815-2550E3FA-EDC2-41A1-96B3-75AE5B4F2313

P2860

Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

Item

http://www.wikidata.org/entity/Q38845457

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

@en

type

Item

label

Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

@en

prefLabel

Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

@en

P1476

Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

@en

P2093

Jyothsna Akam-Venkata

http://www.w3.org/2001/XMLSchema#string

Vivian I Franco

http://www.w3.org/2001/XMLSchema#string

P2860

Cardioprotective interventions for cancer patients receiving anthracyclines

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

Sorafenib in advanced clear-cell renal-cell carcinoma

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

Trastuzumab--mechanism of action and use in clinical practice

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.

Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

P2888

s11936-016-0466-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S11936-016-0466-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steven E Lipshultz

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27230282

http://www.w3.org/2001/XMLSchema#string

Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

about

P2860

P2860

Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698